Across TCGA pan-cancer cohorts, KISS1R RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated KISS1R data layer.
The strongest signal is observed in thymoma (THYM), where higher KISS1R RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KISS1R expression acts as an unfavorable survival marker, although some lineages such as STAD and KIRC show a favorable association.
THYM, UVM, and UCS are the cancer types where KISS1R RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.